Insider · CIK 0001495412
Gerald W. McLaughlin
Files at ALLR (Allarity Therapeutics, Inc.). First filing -, latest -.
Gerald W. McLaughlin files SEC Form 4 as director at ALLR (Allarity Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gerald W. McLaughlin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | ALLR Allarity Therapeutics, Inc. | AGrant or award Common Stock | +45,000 | $0.00 | $0 | 70,000 | May 7, 2026 |
| Jan 22, 2025 | ALLR Allarity Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Jan 24, 2025 |
Questions about Gerald W. McLaughlin
Answered from the filings on this page, as of the latest one.
Is Gerald W. McLaughlin buying or selling?
Gerald W. McLaughlin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gerald W. McLaughlin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gerald W. McLaughlin has 0.
Where does Gerald W. McLaughlin file Form 4?
Gerald W. McLaughlin has filed Form 4 at ALLR (Allarity Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.